Floxuridine Amino Acid Ester Prodrugs: Enhancing Caco-2 Permeability and Resistance to Glycosidic Bond Metabolism

Springer Science and Business Media LLC - Tập 22 Số 9 - Trang 1510-1518 - 2005
Christopher P. Landowski1, Xueqin Song, Philip L. Lorenzi, John M. Hilfinger, Gordon L. Amidon
1Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

T. Kawaguchi, 1985, Chem. Pharm. Bull. (Tokyo), 33, 1652, 10.1248/cpb.33.1652

Y. Nishizawa, 1965, Biochem. Pharmacol., 14, 1605, 10.1016/0006-2952(65)90015-8

S. C. Tobias, 2001, J. Med. Chem., 44, 4475, 10.1021/jm010337r

Y. Wei, 1998, Bioorg. Med. Chem. Lett., 8, 2419, 10.1016/S0960-894X(98)00437-5

B. S. Vig, 2003, Pharm. Res., 20, 1381, 10.1023/A:1025745824632

C. P. Landowski, 2005, Mol. Cancer Ther., 4, 659, 10.1158/1535-7163.MCT-04-0290

J. A. Laar van, 1998, Eur. J. Cancer, 34, 296, 10.1016/S0959-8049(97)00366-3

G. D. Birnie, 1963, Biochemistry, 13, 566, 10.1021/bi00903a031

R. G. Moranand, 1979, Bull. Cancer, 66, 79

K. L. Mukherjee, 1963, Cancer Res., 23, 49

N. K. Chaudhuri, 1959, Biochem. Pharmacol., 1, 328, 10.1016/0006-2952(59)90121-2

E. Harbers, 1959, J. Biol. Chem., 234, 1255, 10.1016/S0021-9258(18)98169-X

F. Kanzawa, 1981, Cancer Chemother. Pharmacol., 6, 19, 10.1007/BF00253005

C. Fletcher, 1985, Drug Intel. Clin. Pharm., 19, 518

L. M. Beauchamp, 1992, Antivir. Chem. Chemother., 3, 157, 10.1177/095632029200300305

H. Han, 1998, Pharm. Res., 15, 1154, 10.1023/A:1011919319810

M. Sugawara, 2000, J. Pharm. Sci., 89, 781, 10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7

H. C. Shin, 2003, Drug Bioavailability/Estimation of Solubility, Permeability and Absorption (Series: Methods and Principles in Medicinal Chemistry) Vol. 18, 245

C. P. Hsu, 1998, Pharm. Res., 15, 1376, 10.1023/A:1011993303397

H. K. Han, 1998, Pharm. Res., 15, 1382, 10.1023/A:1011945420235

J. Gao, 2000, Current Protocols in Pharmacology, 721

S. Weller, 1993, Clin. Pharmacol. Ther., 54, 595, 10.1038/clpt.1993.196

M. E. Ganapathy, 1998, Biochem. Biophys. Res. Commun., 246, 470, 10.1006/bbrc.1998.8628

T. N. Faria, 2004, Mol. Pharm., 1, 67, 10.1021/mp034001k

K. Sawada, 1999, J. Pharmacol. Exp. Ther., 291, 705

H. C. Shin, 2003, Biochem. Biophys. Res. Commun., 307, 696, 10.1016/S0006-291X(03)01259-2

D. Sun, 2002, Pharm. Res., 19, 1400, 10.1023/A:1020483911355

P. W. Woodman, 1980, Cancer Res., 40, 507

R. A. Norman, 2004, Structure (Camb.), 12, 75, 10.1016/j.str.2003.11.018

E. M. Bennett, 2003, J. Biol. Chem., 278, 47110, 10.1074/jbc.M304622200

I. Kim, 2004, Mol. Pharm., 1, 117, 10.1021/mp0499757

S. Fukushima, 1987, Cancer Res., 47, 1930

Z. Xia, 1999, Arch. Pharm. (Weinheim), 332, 286, 10.1002/(SICI)1521-4184(19998)332:8<286::AID-ARDP286>3.0.CO;2-9